Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.122.5 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.40.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.28NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GK.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.13.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.54NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.196NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-3484.59South Korea
B.1.1.57NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.34NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.459NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.117NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.381NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.237NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.382NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.395NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.37NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.61NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.40NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.153NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.33NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.62NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.391NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.448NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Q.1 (Alpha)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.46 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.99 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.120.2 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.528NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.91 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.39NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.617NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XDK.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.58NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.4.1.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.3.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GA.10.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
KC.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
KL.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HC.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-4273.88South Korea
B.1.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.507NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.2.3.17NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FD.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.44NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used